Biotechnology News

LONDON and SOUTH SAN FRANCISCO, Calif., May 16, 2012 (GLOBE NEWSWIRE) -- GlaxoSmithKline plc ("GSK") (LSE:GSK) and Theravance, Inc. ("Theravance") (Nasdaq:THRX) announced today that following approval...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Denne opplysningen er informasjonspliktig etter...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} This information is subject of the disclosure...

PHILADELPHIA, May 16, 2012 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that results from multiple animal studies with the company's Vaxfectin®-formulated plasmid DNA...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;}  Oslo, 16.mai 2012 - PCI Biotech (PCIB) melder i dag...

Read the full announcement...

Læs hele meddelelsen...

May 15, 2012; Copenhagen, Denmark; Interim Report for the First Quarter 2012 Arzerra® net sales increased 32% over Q1 2011 New Drug Application for ofatumumab submitted in...

15. maj 2012: København, Danmark Delårsrapport for første kvartal 2012 Nettoomsætningen for Arzerra‏® steg med 32% i forhold til første kvartal 2011 Registreringsansøgning er blevet...

BioGaia signs exclusive distribution agreements for its oral health products in the Czech Republic, the Benelux countries and South Africa BioGaia has today signed three different agreements, one...